Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16

被引：0
|
作者：
Jacob P. Thyssen
Marjolein de Bruin-Weller
Antonio Costanzo
Susanne Grond
Christopher Schuster
Chunyuan Liu
Maria Jose Rueda
Yun-Fei Chen
Andreas Pinter
Thomas Bieber
机构：
[1] University of Copenhagen,Department of Dermatology, Bispebjerg Hospital
[2] University Medical Center Utrecht,Department of Dermatology and Allergology, National Expertise Center of Atopic Dermatitis
[3] Humanitas University,Dermatology, Department of Biomedical Sciences
[4] Humanitas Research Hospital,Dermatology
[5] Eli Lilly and Company,Department of Dermatology
[6] Medical University of Vienna,Department of Dermatology, Venereology and Allergology
[7] Tigermed-BDM Inc,Department of Dermatology and Allergy
[8] University Hospital Frankfurt,undefined
[9] University Hospital,undefined
[10] Christine Kühne-Center for Allergy Research and Education (CK-CARE),undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Atopic dermatitis; Classification and regression tree analysis; Severe itch;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3574 / 3587
页数：13
相关论文
共 50 条
  • [41] Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients
    Saporito, Rachael C.
    Cohen, David J.
    CASE REPORTS IN DERMATOLOGY, 2016, 8 (02): : 179 - 184
  • [42] Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy
    Achten, Roselie
    Thijs, Judith
    van Der Wal, Marlot
    van Luijk, Chantal
    Bakker, Daphne
    Knol, Edward
    van Luin, Matthijs
    El Amrani, Mohsin
    Delemarre, Eveline
    Elfiky, Ahmed M., I
    de Boer, Joke
    van Wijk, Femke
    de Graaf, Marlies
    de Bruin-Weller, Marjolein
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (04): : 241 - 252
  • [43] Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
    Mele-Ninot, Gemma
    Curto-Barredo, Laia
    Bonfill-Orti, Montserrat
    Exposito-Serrano, Vicente
    Munera-Campos, Monica
    Figueras Nart, Ignasi
    Riquelme-Mc Loughlin, Constanza
    Gomez-Armayones, Sara
    Spertino, Jorge
    Serra-Baldrich, Esther
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (02) : 153 - 162
  • [44] An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis
    Mendes, Jocelyn T.
    Balogh, Esther A.
    Strowd, Lindsay C.
    Feldman, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1027 - 1033
  • [45] VISIBLE: EFFICACY OF GUSELKUMAB AT WEEK 16 IN MODERATE-TO-SEVERE SCALP PSORIASIS PARTICIPANTS WITH LOW BODY SURFACE AREA INVOLVEMENT
    Albrecht, Lorne
    Shahriari, Mona
    Tyring, Stephen
    Moore, Angela
    Smith, Stacy
    Rosenberg, Elizabeth
    Shah, Kush
    Alkousakis, Theo
    Choi, Olivia
    Rowland, Katelyn
    Chan, Daphne
    Jeyarajah, Jenny
    McMichael, Amy
    Alexis, Andrew
    Fakharzadeh, Steven
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [46] Oral difelikefalin improves itch and inflammatory biomarkers in subjects with atopic dermatitis with moderate-to-severe pruritus
    Guttman-Yassky, Emma
    Facheris, Paola
    Da Rosa, Joel Correa
    Estrada, Yeriel
    David, Eden
    Pavel, Ana
    Bose, Swaroop
    Goncalves, Joana
    Nograles, Kristine
    Kim, Brian
    Lebwohl, Mark
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E116 - E116
  • [47] Oral difelikefalin improves itch and inflammatory biomarkers in atopic dermatitis subjects with moderate-to-severe pruritus
    Guttman-Yassky, E.
    Facheris, P.
    Da Rosa, J. Correa
    Del Duca, E.
    Estrada, Y.
    David, E.
    Pavel, A.
    Bose, S.
    Goncalves, J.
    Nograles, K.
    Kim, B.
    Lebwohl, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [48] Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis
    Shahwan, Kathryn T.
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1198 - +
  • [49] Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis
    Reich, Kristian
    Lio, Peter A.
    Bissonnette, Robert
    Alexis, Andrew F.
    Lebwohl, Mark G.
    Pink, Andrew E.
    Kabashima, Kenji
    Boguniewicz, Mark
    Nowicki, Roman J.
    Valdez, Hernan
    Zhang, Fan
    DiBonaventura, Marco
    Cameron, Michael C.
    Clibborn, Claire
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3228 - +
  • [50] Baricitinib treatment results in clinically meaningful itch reduction and enhanced quality of life in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5
    Kwatra, Shawn
    Forman, Seth
    Cruz, Alma
    Ball, Susan
    DeLozier, Amy
    Pierce, Evangeline
    Buchanan, Andrew
    Sun, Luna
    Ding, Yuxin
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB59 - AB59
12345